Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in prognosis after the first postoperative complication.
Silber JH, Rosenbaum PR, Trudeau ME, Chen W, Zhang X, Kelz RR, Mosher RE, Even-Shoshan O. Silber JH, et al. Among authors: trudeau me. Med Care. 2005 Feb;43(2):122-31. doi: 10.1097/00005650-200502000-00005. Med Care. 2005. PMID: 15655425
Preoperative antibiotics and mortality in the elderly.
Silber JH, Rosenbaum PR, Trudeau ME, Chen W, Zhang X, Lorch SA, Kelz RR, Mosher RE, Even-Shoshan O. Silber JH, et al. Among authors: trudeau me. Ann Surg. 2005 Jul;242(1):107-14. doi: 10.1097/01.sla.0000167850.49819.ea. Ann Surg. 2005. PMID: 15973108 Free PMC article.
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update.
Freedman RA, Caswell-Jin JL, Hassett M, Somerfield MR, Giordano SH; Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Expert Panel. Freedman RA, et al. J Clin Oncol. 2024 May 20:JCO2400886. doi: 10.1200/JCO.24.00886. Online ahead of print. J Clin Oncol. 2024. PMID: 38768407
A scoping review to create a framework for the steps in developing condition-specific preference-based instruments de novo or from an existing non-preference-based instrument: use of item response theory or Rasch analysis.
Tsui TCO, Torres SC, Bielecki JM, Mitsakakis N, Trudeau ME, Bremner KE, Davis AM, Krahn MD. Tsui TCO, et al. Among authors: trudeau me. Health Qual Life Outcomes. 2024 May 14;22(1):38. doi: 10.1186/s12955-024-02253-y. Health Qual Life Outcomes. 2024. PMID: 38745165 Free PMC article. Review.
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.
Cazzaniga ME, Ademuyiwa F, Petit T, Tio J, Generali D, Ciruelos EM, Califaretti N, Poirier B, Ardizzoia A, Hoenig A, Lex B, Mouret-Reynier MA, Giesecke D, Isambert N, Masetti R, Pitre L, Wrobel D, Augereau P, Milani M, Rask S, Solbach C, Pritzker L, Noubir S, Parissenti A, Trudeau ME. Cazzaniga ME, et al. Among authors: trudeau me. JNCI Cancer Spectr. 2024 Jan 4;8(1):pkad107. doi: 10.1093/jncics/pkad107. JNCI Cancer Spectr. 2024. PMID: 38113421 Free PMC article.
98 results